Nebulizer Delivery of Intranasal Scopolamine

Clinical trial NCT04999449 · COMPLETED

Trial details

NCT number: NCT04999449
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Scopolamine Motion Sickness

Start date: 2022-01-24
Primary completion: 2025-05-07
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.